title: Optimum low dose CT screening interval for lung cancer: the answer from NELSON?
authors.affiliation: Respiratory Medicine Unit, Nottingham University Hospitals and Honorary Professor, University of Nottingham, David Evans Centre, Nottingham City Hospital Campus, Nottingham, UK.
authors.forename: David R
authors.identifier: 0000-0001-8410-7160
authors.initials: DR
authors.lastname: Baldwin
authors.affiliation: Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
authors.forename: S W
authors.initials: SW
authors.lastname: Duffy
authors.forename: A
authors.initials: A
authors.lastname: Devaraj
authors.affiliation: Royal Brompton and Harefield NHS Foundation Trust and Honorary Senior Lecturer, Imperial College, London, UK.|Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Institute of Translational Medicine, Liverpool, UK.
authors.forename: J K
authors.initials: JK
authors.lastname: Field
mesh_terms: D055088:Early Detection of Cancer; D006801:Humans; D008175:Lung Neoplasms; D008403:Mass Screening; D014057:Tomography, X-Ray Computed
keywords: Imaging/CT MRI etc; Lung Cancer